Gynaecology Marrow Pg 229-238 (Gynaecological Oncology)
50 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the most common type of cervical cancer?

  • Adenocarcinoma
  • Endometrial Carcinoma
  • Squamous Cell Carcinoma (correct)
  • Sarcoma
  • Metaplasia is considered a premalignant condition.

    False

    What is the dynamic area between the old and new squamocolumnar junction called?

    Transformation Zone

    The ______ zone is the most common site for Squamous Cell Carcinoma.

    <p>Transformation</p> Signup and view all the answers

    Match the following features with either Metaplasia or Dysplasia:

    <p>Physiological = Metaplasia Premalignant = Dysplasia Occurs in presence of risk factors = Dysplasia Seen in all females = Metaplasia</p> Signup and view all the answers

    At what age is HPV DNA testing recommended to begin?

    <p>30 years</p> Signup and view all the answers

    The Hybrid Capture technique identifies the specific subtype of HPV.

    <p>False</p> Signup and view all the answers

    What is indicated by a white appearance during visual inspection?

    <p>Dysplastic epithelium</p> Signup and view all the answers

    The presence of bleeding after sexual intercourse is known as ______.

    <p>Post Coital Bleeding (PCB)</p> Signup and view all the answers

    Match the visual inspection appearance with its inference:

    <p>White = Normal epithelium Pink = Dysplastic epithelium Grey = Normal epithelium Stained area = Dysplastic epithelium</p> Signup and view all the answers

    What is the initial test recommended for screening in the general population starting at 30 years old?

    <p>HPV DNA testing</p> Signup and view all the answers

    HPV DNA testing for HIV positive individuals should be repeated every 5-10 years.

    <p>False</p> Signup and view all the answers

    What treatment is preferred for dysplastic epithelium during cervical screening?

    <p>LLETZ</p> Signup and view all the answers

    Cervical screening should start at age _______ and stop at age _______.

    <p>30, 50</p> Signup and view all the answers

    Match the following HPV testing recommendations with their respective patient categories:

    <p>General population = Repeat every 5-10 years HIV positive = Repeat every 3 years Negative HPV result = Repeat testing in 5-10 years Positive HPV result = Repeat testing in 3-5 years</p> Signup and view all the answers

    Which of the following HPV vaccines is nonavalent?

    <p>Gardasil 9</p> Signup and view all the answers

    Screening for gynecologic cancers should start at the age of 21, regardless of sexual activity history.

    <p>True</p> Signup and view all the answers

    What is the recommended frequency for Pap smear tests from age 21 to 30?

    <p>Every 5 years</p> Signup and view all the answers

    The __________ vaccine is bivalent and targets HPV subtypes 16 and 18.

    <p>Cervarix</p> Signup and view all the answers

    Match the HPV vaccine to its characteristics:

    <p>Cervavac = Quadrivalent, protects against genital warts, cervical cancer Gardasil = Quadrivalent, same as Cervavac Cervarix = Bivalent, targets HPV 16 and 18 Gardasil 9 = Nonavalent, covers additional HPV subtypes</p> Signup and view all the answers

    What is the risk of cancer associated with CIN 2?

    <p>~5%</p> Signup and view all the answers

    CIN is diagnosed solely on the basis of a pap smear.

    <p>False</p> Signup and view all the answers

    Which pap smear finding corresponds with the need for antibiotics?

    <p>Infection</p> Signup and view all the answers

    CIN 1 has a cancer risk of approximately ____%.

    <p>1</p> Signup and view all the answers

    Match the following Pap smear findings to their significance:

    <p>Normal = No abnormalities detected ASCUS = Atypical squamous cells of unknown significance HSIL = High squamous intraepithelial lesion AGCUS = Atypical glandular cells of unknown significance</p> Signup and view all the answers

    Which instrument is used to collect a sample from the ectocervix during a pap smear?

    <p>Ayer's spatula</p> Signup and view all the answers

    An endocervical brush is used for taking samples from the ectocervix.

    <p>False</p> Signup and view all the answers

    What does a pap smear primarily identify?

    <p>Dysplasia</p> Signup and view all the answers

    The sample from the ectocervix is collected using a ______ spatula.

    <p>Ayer's</p> Signup and view all the answers

    Match the following cervical conditions with their characteristics:

    <p>CIN 1 = Mild dysplasia CIN 2 = Moderate dysplasia CIN 3 = Severe dysplasia Dysplasia - = Normal cervical cells</p> Signup and view all the answers

    What is the FDA-approved age range for high-risk females to receive the HPV vaccine?

    <p>27 - 45 years</p> Signup and view all the answers

    The goal of the WHO SAGE recommendations is to vaccinate 90% of females by age 18.

    <p>False</p> Signup and view all the answers

    How many doses of the HPV vaccine are recommended for individuals aged 21 years and older?

    <p>3</p> Signup and view all the answers

    Females who are sexually active, females with HPV, and ______ should be administered the HPV vaccine.

    <p>HIV+ve individuals</p> Signup and view all the answers

    Match the following age groups with their recommended HPV vaccine doses:

    <p>9-20 years = 1/2 21 years and older = 3</p> Signup and view all the answers

    What is the best time to perform a pap smear?

    <p>Periovulatory phase</p> Signup and view all the answers

    Liquid-based cytology samples can be tested during menstruation.

    <p>True</p> Signup and view all the answers

    What type of fixation is used in liquid-based cytology?

    <p>Methanol</p> Signup and view all the answers

    Active __________ is a relative contraindication for liquid-based cytology.

    <p>bleeding</p> Signup and view all the answers

    Match the following cytological cell types with their respective counts in Conventional Pap versus Liquid Based Cytology:

    <p>Squamous cells = 8K-10K conventional, 4K-5K liquid Columnar cells = 10-1a in both</p> Signup and view all the answers

    Which screening method is considered the most sensitive for detecting HPV?

    <p>HPV DNA testing</p> Signup and view all the answers

    The WHO goal for vaccination coverage against cervical cancer is set at 80% by age 15.

    <p>False</p> Signup and view all the answers

    What is the recommended age for the start of cervical screening according to the WHO protocol?

    <p>30 years old</p> Signup and view all the answers

    The persistent HPV infection can lead to _____, which may progress to cervical cancer.

    <p>dysplasia</p> Signup and view all the answers

    Match the following screening methods with their characteristics:

    <p>HPV DNA testing = Most sensitive for detecting HPV Pap smear = Most specific method VIA = Recommended by WHO VILI = Not recommended by WHO</p> Signup and view all the answers

    Which of the following HPV subtypes accounts for approximately 50% of cervical cancer cases?

    <p>HPV 16</p> Signup and view all the answers

    HPV 6 and HPV 11 are considered high-risk subtypes for cancer development.

    <p>False</p> Signup and view all the answers

    What is the role of the E1 and E2 proteins in HPV?

    <p>Viral replication and upregulation of E6 and E7</p> Signup and view all the answers

    HPV is known to knock out the ______ gene, resulting in immortal cells.

    <p>p53</p> Signup and view all the answers

    Match the following cancers with the gender primarily affected:

    <p>Cervical Cancer = Females Penis Cancer = Males Vulvar Cancer = Females Anal Cancer = Males</p> Signup and view all the answers

    Study Notes

    HPV Testing and Cervical Abnormalities

    • HPV DNA Testing: Performed at age 30 or older, using the Hybrid Capture technique. Detects high-risk HPV infection but not specific subtypes.
    • Subtype Testing: Includes Onclarity, Cobas, and Partial Genotyping tests.
    • Cotesting (HPV + Pap test): If Pap test shows abnormalities, a follow-up HPV test is conducted. Helps determine HPV infection presence and type.
    • Visual Inspection (VIA and VILI):
      • Acetic Acid (VIA): Applying 3-5% acetic acid highlights dysplastic cells, making them appear white.
      • Visual Inspection with Lugol's Iodine (VILI): Staining with Lugol's iodine differentiates normal (pink) from abnormal (white) epithelium.

    Squamous Metaplasia

    • Definition: Squamous epithelium replaces columnar epithelium.
    • Transformation Zone: Dynamic area between old and new squamocolumnar junction.
    • Position Changes: Influenced by hormonal status, common during pregnancy and menopause.
    • Cancer Cervix:
      • Squamous Cell Carcinoma is the most common type.
      • Transformation Zone is the most common site.
      • Endocervix is usually the site for adenocarcinoma.
    • Pap Smear: Samples are taken from the Transition and Endocervix zones.
    • Metaplasia vs Dysplasia:
      • Metaplasia is physiological, not premalignant, and occurs in all females.
      • Dysplasia is pathological, premalignant, and occurs in the presence of risk factors.

    Gynaecologic Oncology

    • Active Space:
      • HPV DNA approach recommends screening from 30 to 49 years.
      • Repeat HPV DNA testing every 5-10 years (general population) or 3-5 years (HIV positive).
      • Treatment for positive HPV DNA tests includes LLETZ/LEEP or Cryoablation.
      • Cervical Screening (VIA approach): Apply 3-5% acetic acid to the cervical epithelium.
        • Normal epithelium: Repeat screening every 3 years.
        • Dysplastic epithelium: Requires further evaluation and treatment.
    • Management:
      • Repeat HPV DNA test every 1-2 years.
      • LLETZ (Large loop excision of transformation zone).
      • LEEP (Loop electrosurgical excision procedure).
      • Cryosurgery: Applicable for non-HIV patients with dysplastic areas covering less than 2 quadrants of the cervix.
    • General Screening Guidelines:
      • General population: Every 5-10 years.
      • HIV positive: Every 3 years.
      • Screening starts at 30 years and ends at 50 years.

    ACOG Recommendations

    • Screening from 21 years: Pap smear every 5 years until 30 years.
    • Screening from 30-65 years: HPV DNA testing + Pap smear (Cotest) every 5 years.

    Notable Points

    • Hysterectomy: Stop screening after hysterectomy.
    • Begin Sexual Activity before 21: Screening starts at 21 years of age.
    • Females 55-65 years: Continue screening if one abnormal Pap smear is present.
    • Screening: Screening continues up to 75 years of age, even after HPV vaccination.

    HPV Vaccines

    • All vaccines are produced from the L1 capsid protein.
    • Cervavac (Quadrivalent): Subtypes: HPV 6, 11, 16, 18. Protects against genital warts and cervical cancer.
    • Gardasil (Quadrivalent): Subtypes: HPV 6, 11, 16, 18.
    • Cervarix (Bivalent): Subtype: HPV 16, 18.
    • Gardasil 9 (Nonavalent): Subtypes: HPV 6, 11, 16, 18, 31, 33, 45, 52, 58. Most common HPV vaccine in the US.
    • Age Recommendations: Ideal age is 11-12 years, but can be administered from 9-26 years.

    CIN: Part 2

    • CIN: Cervical intraepithelial neoplasia.
    • CIN and Risk of Cervical Cancer:
      • CIN 1: ~1% risk.
      • CIN 2: ~5% risk.
      • CIN 3: ~12-40% risk.
    • Diagnosis: CIN is diagnosed on biopsy, not on a Pap smear.
    • WHO guidelines on management:
      • Limited resource countries: Screening with HPV DNA ± VIA. Biopsy is not mandatory.
      • Resource-rich countries: Abnormal Pap smear leads to biopsy, and CIN 1/2/3 requires further management.

    Pap Smear

    • Normal.
    • Infection: Requires antibiotic treatment.
    • Low squamous intraepithelial lesion (LSIL).
    • High squamous intraepithelial lesion (HSIL).
    • Atypical squamous cells of unknown significance (ASCUS).
    • Atypical squamous cells where HSIL cannot be ruled out (ASC-H).
    • Atypical glandular cells of unknown significance (AGCUS).

    Pap Smear Instruments

    • Ayres spatula: Used to collect samples from the ectocervix.
    • Endocervical brush: Used to collect samples from the endocervix.

    Samples

    • Ectocervix: Sample is taken from the transition zone using a bifid end of Ayres spatula, near the external os.
    • Endocervix: Sample is collected using an endocervical brush.

    Applied Aspect

    • CIN diagnosis: Made through biopsy or tissue sample.
    • Pap smear: Identifies dysplasia, but cannot assess the extent.
    • Abnormal Pap smear: Requires follow-up with biopsy.

    Cervical Epithelial Thickness and Carcinoma

    • Cervical epithelial thickness: Varies with types of carcinoma.

    HPV Vaccine Information

    • High-Risk Females: Approved by FDA for ages 27-45 years. WHO SAGE recommends vaccinating 90% of females by age 15.
    • Dosage:
      • 9-20 years: 1/2 doses.
      • ≥21 years: 3 doses.
    • Recipients:
      • HIV+ve individuals.
      • Sexually active females.
      • Females with HPV.
      • Boys (should be administered).

    Liquid Based Cytology

    • Procedure: Smear samples are put on the same slide and fixed with 95% ethyl alcohol ± 5% ether. Do not air dry the slide.
    • Relative Contraindication: Active bleeding.
    • Best Time: Periovulatory phase.
    • Separate Cervico-vaginal Swab: Collected for HPV DNA testing.
    • Advantages:
      • Same sample for Pap smear and HPV testing.
      • Can be tested during menstruation.
      • Fewer unsatisfactory smears.

    Prevention of HPV Infection

    • Screening: Aims to detect and manage HPV infection.
      • 90% of HPV infections resolve.
      • 10% persist leading to dysplasia, CIN, cancer in situ, and cervical cancer.
    • WHO Goals (2030):
      • 90% coverage for cervical cancer vaccination by 15 years old.
      • 70% screened by 35 years, repeated at 45 years, and receive appropriate treatment.
      • 90% with CIN or cervical cancer treated.
    • Screening Methods:
      • Most sensitive: HPV DNA testing (sensitivity 85-90%).
      • Most specific: Pap smear (sensitivity 55%).
      • Recommended by WHO: VIA (visual inspection with acetic acid).
      • Not recommended by WHO: VILI (visual inspection with Lugol's iodine).
    • Screening Protocol:
      • Resource-rich countries: ACOG protocol.
      • Resource-limited countries: WHO protocol.
      • WHO Protocol: Begins at 30 years old and ends at 50 years old.
    • Approaches:
      • See & treat: 1st screening +ve → HPV DNA testing → VIA.
      • See, triage & treat: 1st screening +ve → 2nd screening +ve → treatment.

    Gynaecologic Oncology

    • HPV: Epitheliotropic virus that completes its life cycle in epithelial cells. Affects basal and parabasal cells, and completes its cycle in superficial cells.
    • Malignant Transformation: Knocks out p53 and retinoblastoma genes, leading to immortal cells.
    • Subtypes and Functions: E1 and E2 proteins are involved in viral replication, upregulating E6 and E7.
    • High-Risk Subtypes:
      • HPV 16 and HPV 18 (70% of cervical cancer cases).
      • HPV 16 (50% of cervical cancer cases).
      • HPV 18 (most specific subtype).
      • Other subtypes (31, 33, 35, 54, 58).
    • Cancer:
      • Males: Penis cancer, anal cancer, oropharyngeal cancer.
      • Females: Cervical cancer, vulvar cancer, vaginal cancer.
    • Low-Risk Subtypes:
      • HPV 6 and 11: Genital warts/Condyloma Acuminata.
      • Treatment for pregnant females: Trichloroacetic acid (TCA).
      • Laryngeal papilloma in newborns.

    Pap Smear Instruments

    • Ayres spatula: Used to collect samples from the ectocervix.
    • Endocervical brush: Used to collect samples from the endocervix.

    Samples

    • Ectocervix: Sample is taken from the transition zone using a bifid end of Ayres spatula, near the external os.
    • Endocervix: Sample is collected using an endocervical brush.

    Applied Aspect

    • CIN diagnosis: Made through biopsy or tissue sample.
    • Pap smear: Identifies dysplasia, but cannot assess the extent.
    • Abnormal Pap smear: Requires follow-up with biopsy.

    Cervical Epithelial Thickness and Carcinoma

    • Cervical epithelial thickness: Varies with types of carcinoma.

    HPV Vaccine Information

    • High-Risk Females: Approved by FDA for ages 27-45 years. WHO SAGE recommends vaccinating 90% of females by age 15.
    • Dosage:
      • 9-20 years: 1/2 doses.
      • ≥21 years: 3 doses.
    • Recipients:
      • HIV+ve individuals.
      • Sexually active females.
      • Females with HPV.
      • Boys (should be administered).

    Liquid Based Cytology

    • Procedure: Smear samples are put on the same slide and fixed with 95% ethyl alcohol ± 5% ether. Do not air dry the slide.
    • Relative Contraindication: Active bleeding.
    • Best Time: Periovulatory phase.
    • Separate Cervico-vaginal Swab: Collected for HPV DNA testing.
    • Advantages:
      • Same sample for Pap smear and HPV testing.
      • Can be tested during menstruation.
      • Fewer unsatisfactory smears.

    Prevention of HPV Infection

    • Screening: Aims to detect and manage HPV infection.
      • 90% of HPV infections resolve.
      • 10% persist leading to dysplasia, CIN, cancer in situ, and cervical cancer.
    • WHO Goals (2030):
      • 90% coverage for cervical cancer vaccination by 15 years old.
      • 70% screened by 35 years, repeated at 45 years, and receive appropriate treatment.
      • 90% with CIN or cervical cancer treated.
    • Screening Methods:
      • Most sensitive: HPV DNA testing (sensitivity 85-90%).
      • Most specific: Pap smear (sensitivity 55%).
      • Recommended by WHO: VIA (visual inspection with acetic acid).
      • Not recommended by WHO: VILI (visual inspection with Lugol's iodine).
    • Screening Protocol:
      • Resource-rich countries: ACOG protocol.
      • Resource-limited countries: WHO protocol.
      • WHO Protocol: Begins at 30 years old and ends at 50 years old.
    • Approaches:
      • See & treat: 1st screening +ve → HPV DNA testing → VIA.
      • See, triage & treat: 1st screening +ve → 2nd screening +ve → treatment.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Test your knowledge on HPV DNA testing, subtype testing, and the significance of co-testing with Pap tests. Explore visual inspection methods and understand squamous metaplasia in the context of cervical health. This quiz aims to reinforce concepts surrounding HPV and cervical abnormalities for health professionals.

    More Like This

    HPV Oncogenic Types Quiz
    17 questions

    HPV Oncogenic Types Quiz

    ExceptionalLanthanum avatar
    ExceptionalLanthanum
    Understanding HPV and Oral Cancers
    8 questions
    IST HPV (item 162-302)
    20 questions

    IST HPV (item 162-302)

    BeneficialTan2398 avatar
    BeneficialTan2398
    MICI: HPV
    20 questions

    MICI: HPV

    ThrivingArgon avatar
    ThrivingArgon
    Use Quizgecko on...
    Browser
    Browser